Halozyme Expands Collaboration With argenx

MT newswire2026/10/06 21:58

05:58 PM EDT, 10/06/2026 (MT Newswires) -- Halozyme Therapeutics (HALO) said late Tuesday it has expanded its global collaboration and license agreement with argenx (ARGX) to develop and commercialize Enhanze. The expanded agreement increases argenx's exclusive access to Enhanze to eight targets from six, the company said. Halozyme said it is eligible to receive payments upon achievement of milestones and will receive royalties on net sales of products using Enhanze, a drug delivery technology.

Disclaimer: The content of this article solely reflects the author's opinion and does not represent the platform in any capacity. This article is not intended to serve as a reference for making investment decisions.

You may also like

MINIMAX drops 10.8% in 1 hour

Odaily星球日报•2026/10/26 02:13

The battle for customer loyalty heats up ahead of the holiday season! Walmart (WMT.US) launches a $120 membership package, going head-to-head with Amazon Prime and Costco.

Walmart launched a joint membership package for Walmart+ and Sam’s Club Plus this week, directly competing with Amazon Prime and Costco.

智通财经•2026/10/26 01:51

Data: ETH falls below 2,300 USD

Chaincatcher•2026/10/26 01:51

Survival period doubled! AstraZeneca's new stomach cancer drug Sone-ve aims for $5 billion in annual sales, ADC takes another step towards replacing chemotherapy

AstraZeneca's gastric cancer ADC doubles patient survival, extending life by five more months, aiming for annual sales of $5 billion; the company is racing with Takeda and Astellas to target Claudin 18.2.

智通财经•2026/10/26 01:36